22/05/2013 13:12:04 Free Membership Login
American Oriental
Bioengineering, Inc.
   

   

American Oriental Bioengineering, Inc.

Visual Financials
American Oriental Bioengineering stock quote | American Oriental Bioengineering company information | American Oriental Bioengineering Stock Chart | American Oriental Bioengineering Stock News
Company Name: American Oriental Bioengineering, Inc.
Ticker Symbol: AOB
WWW Address: www.bioaobo.com
CEO: Mr. Shujun (Tony) Liu
No. of Employees: 4,295
Common Issue Type: CS
Business Description:American Oriental Bioengineering is a fully integrated pharmaceutical company dedicated to improving health through the development, manufacture, commercialization and distribution of a range of pharmaceutical and healthcare products in China.

 
Industry Information: DRUGS - Biotechnology [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 1.52 Unchanged 0.0 - -  1.52 1.52 -
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 59.7 39.3 1.78 0.44 0.00 3.8 0.0 2.72 - 1.00
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close1.52$
PE Ratio - LTM3.8
Market Capitalisation59.7mil
Latest Shares Outstanding39.3mil
Earnings pS (EPS)0.44$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee71,233$
Effective Tax Rate33.8%
Float30.8mil
Float as % of Shares Outstanding78.5%
Foreign Salesmil
Domestic Salesmil
Selling, General & Adm/tive (SG&A) as % of Revenue30.80%
Research & Devlopment (R&D) as % of Revenue5.50%
Gross Profit Margin50.4%
EBITDA Margin14.2%
Pre-Tax Profit Margin8.5%
Assets Turnover0.4%
Return on Assets (ROA)2.3%
Return on Equity (ROE)3.3%
Return on Capital Invested (ROCI)2.6%
Current Ratio4.8
Leverage Ratio (Assets/Equity)1.4
Interest Cover4.3
Total Debt/Equity (Gearing Ratio)0.27
LT Debt/Total Capital19.0%
Working Capital pS4.70$
Cash pS2.12$
Book-Value pS11.65$
Tangible Book-Value pS6.46$
Cash Flow pS0.67$
Free Cash Flow pS0.29$
KEY FIGURES (LTM): Price info
Price/Book Ratio0.13
Price/Tangible Book Ratio0.24
Price/Cash Flow2.3
Price/Free Cash Flow5.2
P/E as % of Industry Group18.0%
P/E as % of Sector Segment5.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week---0.098
4 Weeks1.521.521.520.0106
13 Weeks1.591.111.3611.811673146,761
26 Weeks1.941.101.454.8921,106138,293
52 Weeks2.721.002.50-39.2611,605402,877
YTD1.941.11-35.51291,116112,742
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
1.521.521.521.481.511.782.31
 
GROWTH RATES5-Year
Growh		R² of 5-Year Growth3-Year
Growth
Revenue21.6571.31.05
Income-15.6546.1-32.81
Dividend0.000.00.00
Capital Spending-9.71NA-67.09
R&D0.00NA0.00
Normalized Inc.-16.05NA-36.53
 
CHANGESYTD vs.
Last YTD		Curr Qtr vs.
Qtr 1-Yr ago		Annual vs.
Last Annual
Revenue %-28.1-41.13.3
Earnings %-17.743.6-60.5
EPS %-16.742.9-58.5
EPS $-0.060.06-0.62
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio26.52
Current Ratio4.7
Quick Ratio (Acid Test)4.0
Liquidity Ratio (Cash)2.16
Receivables Turnover4.4
Average Collection Period82
Working Capital/Equity37.7
Working Capital pS4.13
Cash-Flow pS0.76
Free Cash-Flow pS0.05
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio1.22
Financial Leverage Ratio (Assets/Equity)1.4
Debt Ratio29.6
Total Debt/Equity (Gearing Ratio)0.29
LT Debt/Equity0.27
LT Debt/Capital Invested25.1
LT Debt/Total Liabilities63.9
Interest Cover5.2
Interest/Capital Invested1.04
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.45
Tobin's Q Ratio0.10
Current P/E Ratio - LTM3.80
Enterprise Value (EV)/EBITDA3.31
Enterprise Value (EV)/Free Cash Flow138.61
Dividend Yield0.0
Price/Tangible Book Ratio - LTM0.24
Price/Book Ratio - LTM0.13
Price/Cash Flow Ratio2.3
Price/Free Cash Flow Ratio - LTM5.2
Price/Sales Ratio0.25
P/E Ratio (1 month ago) - LTM3.8
P/E Ratio (26 weeks ago) - LTM3.8
P/E Ratio (52 weeks ago) - LTM3.9
5-Y High P/E Ratio28.8
5-Y Low P/E Ratio6.2
5-Y Average P/E Ratio14.9
Current P/E Ratio as % of 5-Y Average P/E26
P/E as % of Industry Group18.0
P/E as % of Sector Segment5.0
Current 12 Month Normalized P/E Ratio - LTM3.8
PER SHARE FIGURES
LT Debt pS2.94
Current Liabilities pS1.12
Tangible Book Value pS - LTM6.46
Book Value pS - LTM11.65
Capital Invested pS13.91
Cash pS - LTM2.12
Cash Flow pS - LTM0.67
Free Cash Flow pS - LTM0.29
Earnings pS (EPS)0.44
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin0.64
Free Cash Flow Margin 5YEAR AVG-12.28
Net Profit Margin5.3
Net Profit Margin - 5YEAR AVRG.15.7
Equity Productivity0.71
Return on Equity (ROE)3.8
Return on Equity (ROE) - 5YEAR AVRG.10.9
Capital Invested Productivity0.56
Return on Capital Invested (ROCI)3.0
Return on Capital Invested (ROCI) - 5YEAR AVRG.8.9
Assets Productivity0.50
Return on Assets (ROA)2.7
Return on Assets (ROA) - 5YEAR AVRG.7.9
Gross Profit Margin50.4
Gross Profit Margin - 5YEAR AVRG.62.2
EBITDA Margin - LTM14.2
EBIT Margin - LTM11.1
Pre-Tax Profit Margin8.1
Pre-Tax Profit Margin - 5YEAR AVRG.20.1
Effective Tax Rate33.8
Effective Tax Rate - 5YEAR AVRG.23.3
EFFICIENCY RATIOS
Cash Conversion Cycle124
Revenue per Employee71,233
Net Income per Employee3,805
Average Collection Period95
Receivables Turnover4.4
Day's Inventory Turnover Ratio29
Inventory Turnover12.5
Inventory/Sales4.1
Accounts Payble/Sales9.57
Assets/Revenue2.00
Net Working Capital Turnover1.89
Fixed Assets Turnover0.75
Total Assets Turnover0.5
Revenue per $ Cash3.24
Revenue per $ Plant2.32
Revenue per $ Common Equity0.71
Revenue per $ Capital Invested0.56
Selling, General & Adm/tive (SG&A) as % of Revenue34.4
SG&A Expense as % of Revenue - 5YEAR AVRG.33.7
Research & Devlopment (R&D) as % of Revenue5.0
R&D Expense as % of Revenue - 5YEAR AVRG.5.0

  


NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's

1 site:2 us amex aob130522 13:12